NasdaqGM:TRVIPharmaceuticals
Assessing Trevi Therapeutics (TRVI) Valuation After Recent Share Price Pullback And Haduvio Expectations
Recent performance snapshot
Trevi Therapeutics (TRVI) has been on many watchlists after a strong past 3 months, even as the stock has drifted down over the past month and past week.
Shares last closed at US$13.50, giving the company a market value of about US$1.89b. The stock is up over the past year and over the past 3 years, but has been weaker over the past month.
See our latest analysis for Trevi Therapeutics.
Recent trading has cooled, with a 7 day share price return of about 3% lower...
